Smith David Ross
- SEC CIK
- 0001650274
No open-market purchases or sales filed in the past year.
Current role at each company
- FTRE Fortrea Holdings Inc.Interim CFOas of Aug 5, 2026
- CRL Charles River Laboratories International, Inc.Corporate Executive VP & CFOas of Mar 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith David Ross as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRL Charles River Laboratories International, Inc.
Corporate Executive VP & CFO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 (view filing) | Mar 3 | 1 day | Smith David RossCorporate Executive VP & CFO | SSale | −8.96K | $282.53 | −$2.53M | −25.8%25.8K after | 5 lots |
| Aug 10, 2021 (view filing) | Aug 9 | 1 day | Smith David RossCorporate Executive VP & CFO | SSale | −1.75K | $407.40 | −$713.0K | −10.8%14.4K after | 2 lots |